Ki-Seong Eom, MD

Catholic Hematology Hospital, Seoul St. Mary’s Hospital, College of Medicine, the Catholic University of Korea, Republic of Korea

Poster(s):

• 1424 - Safety Analysis of Fixed-Duration Acalabrutinib-Venetoclax Combinations vs Chemoimmunotherapy: A Post Hoc Analysis From the Phase 3 AMPLIFY Trial

• 2006 - Understanding the unmet needs in diagnostics and therapeutics of chronic lymphocytic leukemia in Korea